Dr. Cathy Eng

This account is verified. Learn more

@CathyEngMD

VICC Assoc Director, Strategic Relations and Research Partnerships, Exec Director, Young Adult Cancers Program; Co-Chair, NCI GI Steering Committee

Nashville, TN vanderbilthealth.com/cancer/ Joined June 2013

5K Following 12K Followers 12K Posts

Latest posts 5

Pinned post

Dr. Cathy Eng @CathyEngMD Mar 14, 2025

2025 Fast Facts:
🔷154,270 will be diagnosed
🔷 19,330 patients < 50 y/o
We created a video using @Vidyard discussing the benefit of #colorectalcancer #cancerprevention. embed.vidyard.com/share/n8eturSf…
#ColorectalCancerAwarenessMonth @FightCRC @OncoAlert @VUMC_Cancer @VUMCDiscoveries

share.vidyard.com Getting a Colonoscopy: Who, why and when Knowing the signs and symptoms when you need to get a colonoscopy, describing prep and procedure, and importance of getting screened. © Vanderbilt University Medical Center

Dr. Cathy Eng @CathyEngMD 15h

Come join us on Saturday 11/14/2026 in #Nashville @listeningroom for our FREE symposium focused on #earlyonset #cancer and how we can support our #patients!

#colorectal #genitourinary #cancer #supportivecare #bodyimage #sexualfunction #financialtoxicity #CancerPrevention #riskfactors associated with our environment.

Guest speakers: @UTMDAnderson @WashUSurgery @theNCI

@VUMCDiscoveries @VUMChealth @RajivAgarwalMD @fumikochino @Sonyareid07 @DholariaMD @mholtzonline @advocacy @KidneyCancer @Sid423 @FightCRC @ColonCancerCoal @VuMediHemOnc

Vumedi Oncology Verified account @VuMediHemOnc 4d

📈 More adults under 40 are being diagnosed with cancer, and their needs go far beyond treatment.

Dr. Kerry Schaffer & Dr. Rajiv Agarwal @RajivAgarwalMD preview the Vanderbilt-Ingram Young Adult Cancer Symposium on Nov 14, featuring a patient panel, GU & GI sessions and supportive care. @CathyEngMD @VUMCDiscoveries

📅 Register: bit.ly/4zmtSLp

📺 Watch the preview on #Vumedi: bit.ly/4BNHsJE
Sessions will be available on #Vumedi after the event.

#YoungAdultCancer #EarlyOnsetCancer

View quoted post on X

Dr. Cathy Eng @CathyEngMD Oct 30

Only 2 weeks away! #Patients #advocates PLS join us @VUMCDiscoveries 2nd annual #YoungAdult #Cancer Symposium featuring speakers from
@UTMDAnderson @washumedicine @NIH
focused on #colorectal #GU #supportivecare! We want help our YAC community build stronger relationships through engagement and connection!

💠Meet and Greet 11/13/2026 6-8PM
💠Printing House Hotel

💠Meeting Date: 11/14/2026
💠Time: 8AM - 3PM
💠Venue: @listeningroom

Registration: eventbrite.com/e/c-beyond-yac…

@ColonCancerCoal @FightCRC @ACSCAN @wwp @KidneyCancer #nashvilletennessee @mholtzonline

Dr. Cathy Eng @CathyEngMD Oct 25

Interim analysis of HARMONi-GI1 phase III findings of #Ivonescimab (bispecific Ab for PD-1/VEGF) + chemo vs. durvalumab + chemo for treatment-naive #biliarytract #cancer (N=682). 👏👏
🔹Primary endpoint: OS of 14.9M vs. 12.1 (HR = 0.75)
🔹PFS: 8.4 vs. 5.8M; HR = 0.61
🔹ORR = 53.8% vs. 32.5%
🔹Subsequent therapies was 31.8% vs. 45.9% (more so in control arm)
@curecc #cancer #cancerresearch @OncoAlert @SMMT_TX

Dr. Cathy Eng @CathyEngMD Oct 25

CLARITY- Gastric 01 (CG-01) Phase III AZD-0901 (Sone-Ve) in 2L+ met #Claudin 18.2 (+) in #Gastroesophageal #cancer vs. investigators choice (N=594)
Primary endpoints: PFS + OS
🔹OS: 10M vs. 5M (HR = 0.47) 👏
🔹12M OS: 38.1% vs. 18.1%, HR = 0.47 (3rd line)
🔹 12M 42.6% in 2nd line
🔹 ORR: 23.3% vs. 13.8%
🔹PFS: HR = 0.77 was NS in 2L+
🔹PFS: HR = 4.1 vs. 2.7M; HR = 0.56 in 3L+

🔹Need more data in the 2L setting; largest benefit seen in 3L+ setting
#ESMO2026 @OncoAlert #cancerresearch @AstraZeneca